HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EWG Seeks Realistic FDA Review Deadlines In Sunscreen Innovation Act

This article was originally published in The Rose Sheet

Executive Summary

While the Environmental Working Group supports the Sunscreen Innovation Act, it would like to see realistic deadlines put in place to accelerate FDA’s review of sunscreen-ingredient time-and-extent applications without including a default mechanism that would grant free market access to certain sunscreen actives when FDA fails to act within allotted timeframes.

You may also be interested in...



EWG Warms To Sunscreen Use, But Maintains U.S. Products Are Subpar

NGO reiterates concerns about FDA-approved sunscreen ingredients, spray formats and high-SPF products in its 2014 Sunscreen Guide, based on a review of more than 700 sun-protection products available to U.S. consumers. In tandem with this year’s report, EWG launches a Sun Safety campaign encouraging sunscreen use, one of the few components of its messaging with which the Personal Care Products Council agrees.

Dingell Backs Sunscreen TEA Reform As Sun Sets On His Career

The longest-serving member of Congress says he is committed to working with members of both parties to approve the Sunscreen Innovation Act so it can be signed into law this year. The bill would impose tight deadlines on FDA’s review of TEA applications for sunscreen ingredients, eight of which are pending currently.

Sunscreen Bill Would Expedite TEA Decisions, Set Deadlines

The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.

Related Companies

UsernamePublicRestriction

Register

RS019043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel